Well-known metabolic changes consequent to major injury reflect measurable differences integrated over the whole body. Very little direct information is known about individual organ and tissue contributions to these changes at the whole body level. There is a twofold increase in energy expenditure, a 70% increase in the glucose flux, and a 116% increase in free fatty acid flux. Even with state-of-the-art nutritional therapy in these patients, protein degradation exceeds synthesis by 1.3 g/kg/day. It is becoming clear that specific anabolic agents and/or a more effective balance of substrates or the replacement of missing substrates will be necessary to correct this latter finding but more detailed metabolic information will be necessary to design these newer therapies. During the past several years using PET methods, we have developed and validated methods for measuring: blood flow, blood volume, oxygen extraction, oxygen and glucose utilization in tissues, blood flow and oxygen utilization in the liver, and protein synthesis rates in skeletal muscle. Using these new methods and more standard techniques, the hypotheses evaluated in this project address tissue-specific energy and protein synthesis regulation in animals and in patients and are the following: (I) there are tissue- specific energy requirements which include skeletal muscle that are at or below normal levels and for the liver and heart, these energy requirements are two to three-fold or more above normal; (ii) glucose is taken up into skeletal muscle at or below normal rates and undergoing anaerobic glycolysis to produce lactate, alanine, and little energy; (iii) protein synthesis is at or below normal levels in peripheral muscle and these rates can be modified by anabolic factors. To address these hypotheses, we will measure (1) glucose and fatty acid metabolism in skeletal muscle and other organs in rabbits using PET. To obtain a better understanding of the relationship between the PET measurements of glucose and fatty acid utilization and substrate oxidation, simultaneous steady-state kinetic studies of the metabolic fates of [U-14C] glucose and [1-14C] palmitate will be made in these burned and control animals; (2) glucose and fatty acid metabolism in healthy volunteers and burn-injured patients with burn injuries exceeding 15% BSA; (3) muscle protein synthesis rate in skeletal muscle in burn-injured patients and healthy volunteers; and (4) muscle protein synthesis rate in skeletal muscle in burn-injured patients and healthy volunteers after treatment with recombinant growth hormone and increased concentrations of insulin 1200 mol/L.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center (P50)
Project #
2P50GM021700-22
Application #
6271715
Study Section
Project Start
1997-12-01
Project End
1998-11-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
22
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Tao, Rongya; Wang, Caixia; Stöhr, Oliver et al. (2018) Inactivating hepatic follistatin alleviates hyperglycemia. Nat Med 24:1058-1069
Nakazawa, Harumasa; Chang, Kyungho; Shinozaki, Shohei et al. (2017) iNOS as a Driver of Inflammation and Apoptosis in Mouse Skeletal Muscle after Burn Injury: Possible Involvement of Sirt1 S-Nitrosylation-Mediated Acetylation of p65 NF-?B and p53. PLoS One 12:e0170391
Frydman, Galit H; Marini, Robert P; Bakthavatchalu, Vasudevan et al. (2017) Local and Systemic Changes Associated with Long-term, Percutaneous, Static Implantation of Titanium Alloys in Rhesus Macaques (Macaca mulatta). Comp Med 67:165-175
Khan, Mohammed A S; Khan, Mohammed F; Kashiwagi, Shizuka et al. (2017) An ALPHA7 Nicotinic Acetylcholine Receptor Agonist (GTS-21) Promotes C2C12 Myonuclear Accretion in Association with Release of Interleukin-6 (IL-6) and Improves Survival in Burned Mice. Shock 48:227-235
Li, Peng; Tompkins, Ronald G; Xiao, Wenzhong et al. (2017) KERIS: kaleidoscope of gene responses to inflammation between species. Nucleic Acids Res 45:D908-D914
Kashiwagi, Shizuka; Khan, Mohammed A S; Yasuhara, Shingo et al. (2017) Prevention of Burn-Induced Inflammatory Responses and Muscle Wasting by GTS-21, a Specific Agonist for ?7 Nicotinic Acetylcholine Receptors. Shock 47:61-69
Agarwal, Shailesh; Loder, Shawn; Brownley, Cameron et al. (2016) Inhibition of Hif1? prevents both trauma-induced and genetic heterotopic ossification. Proc Natl Acad Sci U S A 113:E338-47
Shank, Erik S; Martyn, Jeevendra A; Donelan, Mathias B et al. (2016) Ultrasound-Guided Regional Anesthesia for Pediatric Burn Reconstructive Surgery: A Prospective Study. J Burn Care Res 37:e213-7
Copps, Kyle D; Hançer, Nancy J; Qiu, Wei et al. (2016) Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase. J Biol Chem 291:8602-17
Law, Nathan C; White, Morris F; Hunzicker-Dunn, Mary E (2016) G protein-coupled receptors (GPCRs) That Signal via Protein Kinase A (PKA) Cross-talk at Insulin Receptor Substrate 1 (IRS1) to Activate the phosphatidylinositol 3-kinase (PI3K)/AKT Pathway. J Biol Chem 291:27160-27169

Showing the most recent 10 out of 110 publications